Supporting Information
Unless otherwise specified, all reactions were carried out under air atmosphere. All reagents were obtained from commercial suppliers and used without further purification. Tetrahydrofuran (THF) was dried over alumina under a nitrogen atmosphere. Oven-dried glassware was used in all cases. Chromatography was performed on silica gel (SiO 2 ; 60Å silica gel, Merck Grade, 70─230 Mesh). GC experiments were carried out with an Agilent 6890N GC-FID on chromatograph equipped with an Agilent column (HP-1, polysiloxane, 24.5 m x 0.32 mm ID x 0.17 μm). The microwave experiments were carried out with a single mode microwave reactor (CEM discover SP system). 1 H and 13 C NMR spectra were measured with a Bruker AV-300 spectrometer in CDCl 3 . NMR chemical shifts are reported in ppm relative to CHCl 3 (7.24 ppm for 1 H and 77.0 ppm for 13 C). IR spectra were recorded on a FT-IR Spectrum GX (Perkin Elmer), and only partial data are listed. Melting points were determined on a MelTemp apparatus and are reported uncorrected. High resolution mass spectroscopy analyses were carried out by Mahidol University at Department of Chemistry Micro-Mass Facility.
II. General Procedure for the Screening and Optimization.
To a 10 mL oven-dried and N 2 -flushed vial equipped with a magnetic stir bar, a mixture of benzoxazole (60.0 mg, 0.50 mmol, 1.00 equiv), hexamethylbenzene (8.1 mg, 0.05 mmol, 0.10 equiv), varied amount of base, halogenating agent and solvent was stirred at room temperature. After 10 min, amine was added, and the mixture was stirred at room temperature for specified time. The reaction progress was monitored by GC on an Agilent 6890N chromatograph equipped with an Agilent column (HP-1, polysiloxane, 24.5 m x 0.32 mm ID x 0.17 μm). The yield was determined by integration of the product peaks relative to hexamethylbenzene as the internal standard. The GC conditions are as follows: initial temp: 150°C (1 min), ramp1 at 
III. General Procedures for the Synthesis of Compounds 3a─l and 5a─d.
General Procedure for the Synthesis of Compounds 3a─l.
To a 20 mL oven-dried and N 2 -flushed scintillation vial equipped with a magnetic stir bar, a mixture of benzoxazole substrate (2.00 mmol, 1.00 equiv), LiOt-Bu (0.48 g, 6.00 mmol, 3.00 equiv), and iodine (0.76 g, 3.00 mmol, 1.50 equiv) in tetrahydrofuran (THF) (4.00 mL, 0.50 M concentration of substrate) was stirred at room temperature. After 10 min, amine (10.0 mmol, 5.00 equiv) was added, and the mixture was stirred at room temperature for an additional 1 h. After the reaction was complete, distilled S-3 deionized H 2 O (10 mL) was added, and the mixture was extracted with EtOAc (2 x 15 mL). The solution was concentrated in vacuo, and the crude product was purified by SiO 2 column chromatography to afford a benzoxazole derivative.
General Procedure for the Synthesis of Compounds 5a─d.
To a 35 mL oven-dried and N 2 -flushed microwave vial equipped with a magnetic stir bar, a mixture of azole substrate (2.00 mmol, 1.00 equiv), LiOt-Bu (0.48 g, 6.00 mmol, 3.00 equiv), and iodine (0.76 g, 3.00 mmol, 1.50 equiv) in tetrahydrofuran (THF) or N,N-dimethylformamide (DMF) (4.00 mL, 0.50 M concentration of substrate) was stirred at room temperature. After 1 min, the vial was capped and the mixture was heated at 100 o C (in case of THF solvent) or 140 o C (in case of DMF solvent) for 2 h by a single mode microwave reactor (CEM discover SP system). After 2 h, morpholine 2a (0.87 g, 10.0 mmol, 5.00 equiv) was added, and the mixture was then heated by microwave reactor at 100 o C (THF solvent) or 140 o C (DMF solvent) for an additional 2 h. After the reaction was complete, distilled deionized H 2 O (10 mL) was added, and the mixture was extracted with EtOAc (2 x 15 mL). The solution was concentrated in vacuo, and the crude product was purified by SiO 2 column chromatography to afford a desired product.
IV. Analytical Data for Compounds 3a─l and 5a─d.

2-(Morpholin-4-yl)benzoxazole (3a).
1─5 Compound 3a was prepared from benzoxazole 1a (0.24 g, 2.00 mmol) and morpholine 2a (0.87 g, 10.0 mmol) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 4:1) to afford pure compound 3a (0.40 g, 98%) as a yellow-orange solid. 1 
2-(Piperidin-1-yl)benzoxazole (3b).
1─5 Compound 3b was prepared from benzoxazole 1a (0.24 g, 2.00 mmol) and piperidine 2b (0.85 g, 10.0 mmol) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 4:1) to afford pure compound 3b (0.35 g, 87%) as a pale yellow solid. 1 
2-(4-Methylpiperazin-1-yl)benzoxazole (3f).
1─3 Compound 3f was prepared from benzoxazole 1a (0.24 g, 2.00 mmol, 1.00 equiv) and methylpiperazine 2f (1.00 g, 10.0 mmol, 5.00 equiv) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , EtOAc:MeOH = 4:1) to afford pure compound 3f (0.40 g, 93%) as a brown oil. tert-Butyl-4-(Benzoxazol-2-yl)piperazine-1-carboxylate (3g). 4 Compound 3g was prepared from benzoxazole 1a (0.24 g, 2.00 mmol) and tert-butyl piperazine-1-carboxylate 2g (1.86 g, 10.0 mmol) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 4:1) to afford pure compound 3g (0.50 g, 83%) as a yellow solid. 1 N-Cyclohexylbenzoxazole-2-amine (3h). 6 Compound 3h was prepared from benzoxazole 1a (0.24 g, 2.00 mmol) and cyclohexylamine 2h (1.00 g, 10.0 mmol) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 4:1) to afford pure compound 3h (0.26 g, 61%) as an orange-brown solid. 1 N-Benzylbenzoxazole-2-amine (3i). 6 Compound 3i was prepared from benzoxazole 1a (0.24 g, 2.00 mmol) and benzylamine 2i (1.07 g, 10.0 mmol) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 4:1) to afford pure compound 3i (0.20 g, 45%) as a pale yellow solid. 1 134.2, 128.1, 127.5, 124.1, 122.1, 121.8, 120.3, 117.6, 113.9, 109.1. IR (film): 3446, 3358, 3061, 1642,  1577, 1531, 1456, 1334, 1240, 1165, 1003, 974, 822 
5-Chloro-2-(morpholin-4-yl)benzoxazole (3k).
5-Chloro-2-(piperidin-1-yl)benzoxazole (3l)
. 4 Compound 3l was prepared from 5-chlorobenzoxazole 1b (0.31 g, 2.00 mmol) and piperidine 2b (0.85 g, 10.0 mmol) following the general procedure. The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 4:1) to afford pure compound 3l (0.31 g, 65%) as a pale yellow solid. 1 
2-(Morpholin-4-yl)benzothiazole (5a).
7─8 Compound 5a was prepared from benzothiazole 4a (0.27 g, 2.00 mmol) and morpholine 2a (0.87 g, 10.0 mmol) following the microwave heating procedure (in THF at 100 o C). The crude product was further purified by flash column chromatography (SiO 2 , hexanes:EtOAc = 3:1) to afford pure compound 5a (0.24 g, 54%) as an off-white solid. 1 
1-Methyl-2-(morpholin-4-yl)benzimidazole (5c)
. 9 Compound 5c was prepared from benzimidazole 4c (0.26 g, 2.00 mmol) and morpholine 2a (0.87 g, 10.0 mmol) following the microwave heating procedure (in THF at 100 o C). The crude product was further purified by flash column chromatography (SiO 2 , EtOAc:MeOH = 9:1) to afford pure compound 5c (0.14 g, 33%) as an off-white solid. 1 
1,3,7-Trimethyl-8-morpholin-4-yl-3,7-dihydro-1H-purine-2,5-dione (5d).
10
Compound 5d was prepared from caffeine 4d (0.39 g, 2.00 mmol) and morpholine 2a (0.87 g, 10.0 mmol) following the microwave heating procedure (in DMF at 140 o C). The crude product was further purified by flash column chromatography (SiO 2 , EtOAc) to afford pure compound 5d (0.18 g, 31%) as a white solid. mp = 160.9─161. 
